WuXi Biologics is a Hong Kong-listed company with the world’s leading open, integrated biopharmaceutical capabilities and technology empowerment platform. It is committed to providing a full range of end-to-end R&D services for global biopharmaceutical companies and biotechnology companies. WuXi Biologics Suzhou Testing is located in Suzhou, China. It is a biopharmaceutical safety testing company under WuXi Biologics. It is also the first company known in Asia that is capable of conducting international standard biopharmaceutical safety research.
On November 1, WuXi Biologics announced that the company’s Suzhou WuXi Inspection and Testing Co., Ltd.’s new laboratory building in Wuzhong District, Suzhou has officially opened. After the opening of the new laboratory building, WuXi Biologics Suzhou’s testing area will exceed 16,000 square meters. The laboratory equipment is advanced, with more than 600 sets (sets) of world-class equipment and instruments, including 12 AKTAs, 1 transmission electron microscope, 68 real-time quantitative PCR, 1 Ion PGM ion personalized genome sequencer, etc.
WuXi Biologics Suzhou Testing is one of the largest third-party biopharmaceutical safety testing organizations in Asia that can provide international standards (USP, EP, JP) and Chinese standards (CN). After the new laboratory building is fully launched, the company will further enhance its service capabilities and provide global partners with professional, rapid, high-quality, comprehensive, and more cost-effective biological drug safety testing and inspection services.
Heal Force expresses sincere congratulations on the full opening of the new laboratory building for Yaoming Biology. In recent years, the inspection and testing industry has developed vigorously, driving rapid progress in laboratory construction. Hand in hand with the future to jointly lay a solid foundation for the high-quality development of the biomedical research industry.